Not Signed In - Pharmion Announces FDA Acceptance Of IND For Oral Azacitidine
Thu, 01 Feb 2007 08:00 AM EST
... Pharmion Corporation (Nasdaq: PHRM) today announced that the Investigational New Drug (IND) application for the Company's oral formulation of azacitidine is now active following its acceptance by the U.S. Food and Drug Administration (FDA). The Company submitted the IND for oral azacitidine in December 2006. [click link for full article] ...
Related Topics
- Azacitidine
- Oral Cancer
- Oral Health
- Azacitidine Injection
- Tacrolimus ointment
- Amoxicillin Oral Suspension
- Mammography
- Zidovudine Oral Syrup
- Carcinogens
- Bismuth Subsalicylate Oral Liquid
- Sumatriptan Oral
- Ergocalciferol, Vitamin D2 Oral Solution
- Pimecrolimus Cream 1%
- Stavudine Oral Solution
- Dietary Guidelines
- Metronidazole Oral
- Erythromycin Oral Suspension
- Terbinafine Oral
- Fluconazole Oral
- Mesoridazine Oral Concentrate
email this page
print this page
bookmark this page
feedback on this page
